Justin Fallon

Founder at Bolden Therapeutics, Inc.

Health Technology

Profile

Justin Fallon is the founder of Bolden Therapeutics, Inc. and Tivorsan Pharmaceuticals, Inc. At Bolden Therapeutics, he held no specific title.
At Tivorsan Pharmaceuticals, he held the title of Director, but is no longer active in that role.

Justin Fallon active positions

Companies	Position	Start
Bolden Therapeutics, Inc. Bolden Therapeutics, Inc. BiotechnologyHealth Technology Bolden Therapeutics, Inc. is a biotechnology company that is developing first-in-class therapeutics to treat central nervous system diseases. The company's research facilities are based within Tufts Launchpad Biolabs, a leading incubator for next-generation powerhouse biotech startups located in Providence, RI. The company's scientific co-founders, Dr. Justin Fallon and Dr. Ashley E. Webb, have identified a key molecular pathway to stimulate neural stem cells to promote the birth of new neurons in the adult brain. Bolden is developing antisense oligonucleotides to modulate this genetically-validated target. The company was founded by Justin Fallon, Ashley E. Webb, and Johnny Page. Johnny Page has been the CEO since incorporation.	Founder	-

All active positions of Justin Fallon

Former positions of Justin Fallon

Companies	Position	End
Tivorsan Pharmaceuticals, Inc. Tivorsan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tivorsan Pharmaceuticals, Inc. is a protein therapeutics firm. It develops products to treat Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD). The company was founded by Justin Fallon and Joel Bennett Braunstein and is headquartered in Providence, RI.	Founder	-

See the detail of Justin Fallon's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Justin Fallon's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Bolden Therapeutics, Inc. Bolden Therapeutics, Inc. BiotechnologyHealth Technology Bolden Therapeutics, Inc. is a biotechnology company that is developing first-in-class therapeutics to treat central nervous system diseases. The company's research facilities are based within Tufts Launchpad Biolabs, a leading incubator for next-generation powerhouse biotech startups located in Providence, RI. The company's scientific co-founders, Dr. Justin Fallon and Dr. Ashley E. Webb, have identified a key molecular pathway to stimulate neural stem cells to promote the birth of new neurons in the adult brain. Bolden is developing antisense oligonucleotides to modulate this genetically-validated target. The company was founded by Justin Fallon, Ashley E. Webb, and Johnny Page. Johnny Page has been the CEO since incorporation.	Health Technology
Tivorsan Pharmaceuticals, Inc. Tivorsan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tivorsan Pharmaceuticals, Inc. is a protein therapeutics firm. It develops products to treat Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD). The company was founded by Justin Fallon and Joel Bennett Braunstein and is headquartered in Providence, RI.	Health Technology